Global, regional and national epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021
BackgroundMultiple myeloma (MM) is a growing global public health challenge. Known epidemiological data suggest that MM accounts for approximately 10% of all hematologic malignancies and remains the second most common hematologic cancer worldwide. This study utilized data from the 2021 Global Burden...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1527198/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832585056744374272 |
|---|---|
| author | Linmin Zhuge Xiaowu Lin Ziwei Fan Mengxian Jia Chaowei Lin Minyu Zhu Honglin Teng Guoliang Chen |
| author_facet | Linmin Zhuge Xiaowu Lin Ziwei Fan Mengxian Jia Chaowei Lin Minyu Zhu Honglin Teng Guoliang Chen |
| author_sort | Linmin Zhuge |
| collection | DOAJ |
| description | BackgroundMultiple myeloma (MM) is a growing global public health challenge. Known epidemiological data suggest that MM accounts for approximately 10% of all hematologic malignancies and remains the second most common hematologic cancer worldwide. This study utilized data from the 2021 Global Burden of Diseases (GBD) study to evaluate the prevalence, incidence, mortality, disability-adjusted life years (DALYs), and attributable risk factors of MM from 1990 to 2021, and to project future trends for the next 15 years.MethodsGBD 2021 data were analyzed to assess MM’s global burden using four key epidemiological measures: prevalence, incidence, mortality, and DALYs. Estimates are reported per 100,000 population with uncertainty intervals (UI). Temporal trends were assessed through estimated annual percentage change (EAPC) and 95% confidence intervals (CI). All analyses were conducted using R version 4.2.1.ResultsFrom 1990 to 2021, global MM prevalence, incidence, mortality, and DALYs more than doubled, particularly among males. All Social-Demographic Index (SDI) regions showed increases in ASPR, ASIR, ASMR, and ASDR (all EAPCs >0), with the middle SDI regions exhibiting the most rapid growth. ARIMA model predictions suggest that the MM burden will continue rising over the next 15 years. The proportion of MM cases attributable to high BMI also increased globally, from 6.40% in 1990 to 7.96% in 2021. MM primarily affects older adults, with the highest incidence observed in the 70–74 age group and the highest mortality rate recorded in the same age range.ConclusionMM presents an escalating global health challenge. Targeted preventive interventions and improvements in diagnosis, treatment, and care are critical, especially in underdeveloped regions, to address the growing global burden of MM. |
| format | Article |
| id | doaj-art-3b188fb3e2bd4892b8294146d1545d32 |
| institution | Kabale University |
| issn | 2296-2565 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj-art-3b188fb3e2bd4892b8294146d1545d322025-01-27T05:14:34ZengFrontiers Media S.A.Frontiers in Public Health2296-25652025-01-011310.3389/fpubh.2025.15271981527198Global, regional and national epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021Linmin Zhuge0Xiaowu Lin1Ziwei Fan2Mengxian Jia3Chaowei Lin4Minyu Zhu5Honglin Teng6Guoliang Chen7Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Orthopedics (Spine Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Orthopedics (Spine Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Orthopedics (Spine Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Orthopedics (Spine Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Orthopedics (Spine Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Orthopedics (Spine Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaDepartment of Orthopedics (Spine Surgery), The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaBackgroundMultiple myeloma (MM) is a growing global public health challenge. Known epidemiological data suggest that MM accounts for approximately 10% of all hematologic malignancies and remains the second most common hematologic cancer worldwide. This study utilized data from the 2021 Global Burden of Diseases (GBD) study to evaluate the prevalence, incidence, mortality, disability-adjusted life years (DALYs), and attributable risk factors of MM from 1990 to 2021, and to project future trends for the next 15 years.MethodsGBD 2021 data were analyzed to assess MM’s global burden using four key epidemiological measures: prevalence, incidence, mortality, and DALYs. Estimates are reported per 100,000 population with uncertainty intervals (UI). Temporal trends were assessed through estimated annual percentage change (EAPC) and 95% confidence intervals (CI). All analyses were conducted using R version 4.2.1.ResultsFrom 1990 to 2021, global MM prevalence, incidence, mortality, and DALYs more than doubled, particularly among males. All Social-Demographic Index (SDI) regions showed increases in ASPR, ASIR, ASMR, and ASDR (all EAPCs >0), with the middle SDI regions exhibiting the most rapid growth. ARIMA model predictions suggest that the MM burden will continue rising over the next 15 years. The proportion of MM cases attributable to high BMI also increased globally, from 6.40% in 1990 to 7.96% in 2021. MM primarily affects older adults, with the highest incidence observed in the 70–74 age group and the highest mortality rate recorded in the same age range.ConclusionMM presents an escalating global health challenge. Targeted preventive interventions and improvements in diagnosis, treatment, and care are critical, especially in underdeveloped regions, to address the growing global burden of MM.https://www.frontiersin.org/articles/10.3389/fpubh.2025.1527198/fullGlobal Burden of Diseasemultiple myelomaprevalenceincidencemortalitydisability-adjusted life-years |
| spellingShingle | Linmin Zhuge Xiaowu Lin Ziwei Fan Mengxian Jia Chaowei Lin Minyu Zhu Honglin Teng Guoliang Chen Global, regional and national epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021 Frontiers in Public Health Global Burden of Disease multiple myeloma prevalence incidence mortality disability-adjusted life-years |
| title | Global, regional and national epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021 |
| title_full | Global, regional and national epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021 |
| title_fullStr | Global, regional and national epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021 |
| title_full_unstemmed | Global, regional and national epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021 |
| title_short | Global, regional and national epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021 |
| title_sort | global regional and national epidemiological trends of multiple myeloma from 1990 to 2021 a systematic analysis of the global burden of disease study 2021 |
| topic | Global Burden of Disease multiple myeloma prevalence incidence mortality disability-adjusted life-years |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1527198/full |
| work_keys_str_mv | AT linminzhuge globalregionalandnationalepidemiologicaltrendsofmultiplemyelomafrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021 AT xiaowulin globalregionalandnationalepidemiologicaltrendsofmultiplemyelomafrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021 AT ziweifan globalregionalandnationalepidemiologicaltrendsofmultiplemyelomafrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021 AT mengxianjia globalregionalandnationalepidemiologicaltrendsofmultiplemyelomafrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021 AT chaoweilin globalregionalandnationalepidemiologicaltrendsofmultiplemyelomafrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021 AT minyuzhu globalregionalandnationalepidemiologicaltrendsofmultiplemyelomafrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021 AT honglinteng globalregionalandnationalepidemiologicaltrendsofmultiplemyelomafrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021 AT guoliangchen globalregionalandnationalepidemiologicaltrendsofmultiplemyelomafrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021 |